Skip to main content
. Author manuscript; available in PMC: 2013 Mar 26.
Published in final edited form as: J Immunol. 2006 Jul 1;177(1):712–721. doi: 10.4049/jimmunol.177.1.712

FIGURE 3.

FIGURE 3

Hierarchy of HCC patient responses to AFP peptides ex vivo. A, The hierarchy of response to AFP-derived peptides is shown for HCC patient A3. PBMC were thawed, and separated CD8 cells were plated directly in the IFN-γ ELISPOT with K562/A2.1 cells pulsed with individual peptides to determine the frequencies of peptide-specific T cells. T cells were detected to most of the peptides, with the highest frequency responses to AFP1, AFP218, and AFP158. B, The hierarchy of response to AFP-derived peptides is shown for HCC patient B1. Cells were plated as above and the only responses were to epitopes AFP137, AFP1, AFP306, and AFP542. C, The median frequencies to each AFP peptide, for all six HCC patients (A3, A4, B1, B10, B11, B12) are shown; error bars indicate the first and fourth quartiles. The two-sided Wilcoxon test shows that, together, the six HCC patients have higher frequencies of T cells to the four immunodominant peptides, compared with the sum of the subdominant peptide frequencies (p = 0.023).